| 1 |
30622252 | ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks. | 2019 Jan 8 |
1 |
| 2 |
30104007 | Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA status. | 2018 |
1 |
| 3 |
24457564 | The effect of germ-line BRCA mutations on response to chemotherapy and outcome of recurrent ovarian cancer. | 2014 Mar |
1 |
| 4 |
23548269 | ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. | 2013 Jun 15 |
1 |
| 5 |
21855118 | Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers. | 2011 Nov |
5 |
| 6 |
22101337 | Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent. | 2011 Dec 1 |
1 |